Menlo Therapeutics Inc. Employee Directory
Pharmaceutical ManufacturingCalifornia, United States0-1 Employees
Menlo Therapeutics Inc. is a late-stage biopharmaceutical company based in Redwood City, California. It is focused on the development and potential commercialization of serlopitant, a highly selective inhibitor of the neurokinin-1 receptor, to treat pruritus associated with various conditions. Serlopitant is being developed as a once-daily oral tablet intended to alleviate itch. The company operates in the pharmaceutical manufacturing sector and has a very small workforce. In 2020, Menlo Therapeutics publicly introduced AMZEEQ, a product aimed at treating moderate to severe acne in pediatric patients aged nine years and above and adults. The company’s corporate activity around that time includes a merger with Foamix in February 2020.